NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Pacira BioSciences, Inc. (NASDAQ:PCRX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:

You might also be interested in reading Shanghai Man: AscendEX reopened after $80m hack, Huobi suffers key personnel departures, and government officials punished for mining activities.